Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | MPI | P34949 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.36 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL131366 | 0.72 | ALDH1A1 (0.59) | ALDH1A1HSD17B10HPGDCYP3A4TSHR | |
| SCHEMBL4924307 | 0.72 | CES1 (0.45) | ALDH1A1HSD17B10HPGDCYP3A4TSHR | |
| SCHEMBL7742191 | 0.72 | CES1 (0.39) | ALDH1A1HSD17B10HPGDCYP3A4TSHR | |
| SCHEMBL7741267 | 0.72 | ALDH1A1 (0.34) | ALDH1A1HSD17B10HPGDCYP3A4TSHR | |
| SCHEMBL10978229 | 0.72 | ALDH1A1 (0.34) | ALDH1A1HSD17B10HPGDCYP3A4TSHR | |
| Bromide SCHEMBL8715148 | 0.71 | ALDH1A1 (0.57) | ALDH1A1HSD17B10HPGDCYP3A4TSHR | |
| Hydrochloric Acid SCHEMBL8711400 | 0.71 | ALDH1A1 (0.57) | ALDH1A1HSD17B10HPGDCYP3A4TSHR | |
| SCHEMBL8766037 | 0.68 | ALDH1A1 (0.45) | ALDH1A1HSD17B10HPGDCYP3A4TSHR | |
| SCHEMBL29584259 | 0.65 | ALDH1A1 (0.56) | ALDH1A1HSD17B10HPGDCYP3A4TSHR | |
| SCHEMBL5379749 | 0.65 | ALDH1A1 (0.40) | ALDH1A1HSD17B10HPGDCYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304795-A1 | Sulfonyl-bridged perinones | LANXESS DEUTSCHLAND GMBH (DE) | 2025-10-02 | — | — | US | disclosed |
| US-6833455-B2 | Coloring plastics | BAYER AKTIENGESELLSCHAFT (DE) | 2004-12-21 | — | — | US | disclosed |
| US-20030139498-A1 | Bridged perinones/quinophthalones | BAYER AKTIENGESELLSCHAFT (DE) | 2003-07-24 | — | — | US | disclosed |
| EP-0780444-B1 | Process to manufacture polycyclic compounds | BAYER AG (DE) | 2001-09-05 | — | — | EP | disclosed |
| US-5830931-A | DYEING SYNTHETIC HYDROPHOBIC MATERIAL | BAYER AKTIENGESELLSCHAFT (DE) | 1998-11-03 | — | — | US | disclosed |
| EP-0780444-A2 | Process to manufacture polycyclic compounds | BAYER AG (DE) | 1997-06-25 | — | — | EP | disclosed |
| US-5530130-A | DYEING PLASTICS | BAYER AKTIENGESELLSCHAFT (DE) | 1996-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030139498-A1 | Bridged perinones/quinophthalones | CYP11B1, CYP1B1, CYP11B2 | ALDH1A1 310/4885HSD17B10 58/4885HPGD 553/4885 |
| US-20250304795-A1 | Sulfonyl-bridged perinones | SDHA, CYP1B1, CYP2D6 | ALDH1A1 203/4885HSD17B10 54/4885HPGD 373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.